Please wait while the formulary information is being retrieved.
TOPIRAMATE (TOPIRAMATE)
- Complex-partial epilepsy
- Migraine prevention
- Simple-partial epilepsy
- Lennox-gastaut epilepsy
- Tonic-clonic epilepsy
100 mg tablet
- 1 tablet (100 mg) by oral route 2 times per day
200 mg tablet
- 1 tablet (200 mg) by oral route 2 times per day
25 mg tablet
- 1 tablet (25 mg) by oral route once daily
50 mg tablet
- 1 tablet (50 mg) by oral route 2 times per day
15 mg sprinkle capsule
- 1 capsule (15 mg) by oral route 2 times per day in the morning and evening
25 mg sprinkle capsule
- 2 capsules (50 mg) by oral route 2 times per day in the morning and evening
100 mg tablet
- 1 tablet (100 mg) by oral route 2 times per day
200 mg tablet
- 1 tablet (200 mg) by oral route 2 times per day
25 mg tablet
- 1 tablet (25 mg) by oral route once daily
50 mg tablet
- 1 tablet (50 mg) by oral route 2 times per day
15 mg sprinkle capsule
- 1 capsule (15 mg) by oral route 2 times per day in the morning and evening
25 mg sprinkle capsule
- 2 capsules (50 mg) by oral route 2 times per day in the morning and evening
Complex-partial epilepsy
- 1 capsule (15 mg) by oral route 2 times per day in the morning and evening
- 2 capsules (30 mg) by oral route 2 times per day in the morning and evening
- 2 tablets (50 mg) by oral route 2 times per day in the morning and evening
- 2 capsules (50 mg) by oral route 2 times per day in the morning and evening
- 1 tablet (50 mg) by oral route 2 times per day
- 2 tablets (100 mg) by oral route 2 times per day
- 1 tablet (100 mg) by oral route 2 times per day
- 2 tablets (200 mg) by oral route 2 times per day
- 1 tablet (200 mg) by oral route 2 times per day
Essential tremor
- 1 tablet (25 mg) by oral route once daily
- 1 tablet (25 mg) by oral route once daily at bedtime
- 2 tablets (50 mg) by oral route once daily at bedtime
- 2 tablets (50 mg) by oral route once daily
Lennox-gastaut epilepsy
- 1 capsule (15 mg) by oral route 2 times per day in the morning and evening
- 2 capsules (30 mg) by oral route 2 times per day in the morning and evening
- 2 tablets (50 mg) by oral route 2 times per day in the morning and evening
- 2 capsules (50 mg) by oral route 2 times per day in the morning and evening
- 1 tablet (50 mg) by oral route 2 times per day
- 2 tablets (100 mg) by oral route 2 times per day
- 1 tablet (100 mg) by oral route 2 times per day
- 2 tablets (200 mg) by oral route 2 times per day
- 1 tablet (200 mg) by oral route 2 times per day
Migraine prevention
- 1 tablet (25 mg) by oral route once daily
- 1 tablet (25 mg) by oral route once daily at bedtime
- 2 capsules (50 mg) by oral route 2 times per day in the morning and evening
- 2 tablets (50 mg) by oral route once daily at bedtime
- 1 tablet (50 mg) by oral route 2 times per day
- 2 tablets (50 mg) by oral route once daily
Simple-partial epilepsy
- 1 capsule (15 mg) by oral route 2 times per day in the morning and evening
- 2 capsules (30 mg) by oral route 2 times per day in the morning and evening
- 2 tablets (50 mg) by oral route 2 times per day in the morning and evening
- 2 capsules (50 mg) by oral route 2 times per day in the morning and evening
- 1 tablet (50 mg) by oral route 2 times per day
- 2 tablets (100 mg) by oral route 2 times per day
- 1 tablet (100 mg) by oral route 2 times per day
- 2 tablets (200 mg) by oral route 2 times per day
- 1 tablet (200 mg) by oral route 2 times per day
Tonic-clonic epilepsy
- 1 capsule (15 mg) by oral route 2 times per day in the morning and evening
- 2 capsules (30 mg) by oral route 2 times per day in the morning and evening
- 2 tablets (50 mg) by oral route 2 times per day in the morning and evening
- 2 capsules (50 mg) by oral route 2 times per day in the morning and evening
- 1 tablet (50 mg) by oral route 2 times per day
- 2 tablets (100 mg) by oral route 2 times per day
- 1 tablet (100 mg) by oral route 2 times per day
- 2 tablets (200 mg) by oral route 2 times per day
- 1 tablet (200 mg) by oral route 2 times per day
- None
Contraindicated
- acetazolamide
- acetazolamide sodium
- Altavera (28)
- Alyacen 1/35 (28)
- Alyacen 7/7/7 (28)
- Amethia
- Amethia Lo
- Amethyst
- Apri
- Aranelle (28)
- Aubra
- Aviane
- Azopt
- Azurette (28)
- Balziva (28)
- Beyaz
- Brevicon (28)
- Briellyn
- brinzolamide
- brinzolamide-brimonidine
- Camila
- Camrese
- Camrese Lo
- Caziant (28)
- Chateal
- Cosopt
- Cosopt Pf
- Cryselle (28)
- Cyclafem 1/35 (28)
- Cyclafem 7/7/7 (28)
- Cyclessa (28)
- Dasetta 1/35 (28)
- Dasetta 7/7/7 (28)
- Daysee
- desog-e.estradiol/e.estradiol
- Desogen
- desogestrel-ethinyl estradiol
- Diamox Sequels
- dorzolamide
- dorzolamide-timolol
- dorzolamide-timolol (PF)
- drospirenone-e.estradiol-lm.FA
- drospirenone-ethinyl estradiol
- Elinest
- Emoquette
- Enpresse
- Enskyce
- Errin
- Estarylla
- estradiol valerate-dienogest
- Estrostep Fe-28
- ethynodiol diac-eth estradiol
- etonogestrel
- etonogestrel-ethinyl estradiol
- Falmina (28)
- Femcon Fe
- Generess Fe
- Gianvi (28)
- Gildagia
- Gildess
- Gildess Fe
- Heather
- Introvale
- Jencycla
- Jolessa
- Jolivette
- Junel 1.5/30 (21)
- Junel 1/20 (21)
- Junel Fe 1.5/30 (28)
- Junel Fe 1/20 (28)
- Kariva (28)
- Kelnor 1/35 (28)
- Kurvelo
- L norgest&E estradiol-E estrad
- Larin 1/20 (21)
- Larin Fe
- Leena 28
- Lessina
- Levonest (28)
- levonorg-eth estrad triphasic
- levonorgestrel
- levonorgestrel-ethinyl estrad
- Levora 0.15/30 (28)
- Levora-28
- Lo Loestrin Fe
- Loestrin 1.5/30 (21)
- Loestrin 1/20 (21)
- Loestrin Fe 1.5/30 (28)
- Loestrin Fe 1/20 (28)
- Lomedia 24 Fe
- Loryna (28)
- Loseasonique
- Low-ogestrel (28)
- Lutera (28)
- Lyza
- Marlissa
- methazolamide
- Microgestin 1.5/30 (21)
- Microgestin 1/20 (21)
- Microgestin Fe 1.5/30 (28)
- Microgestin Fe 1/20 (28)
- Minastrin 24 Fe
- Mircette (28)
- Mirena
- Modicon (28)
- Mono-linyah
- Mononessa (28)
- My Way
- Myzilra
- Natazia
- Necon 0.5/35 (28)
- Necon 1/35 (28)
- Necon 1/50 (28)
- Necon 10/11 (28)
- Necon 7/7/7 (28)
- Neptazane
- Nexplanon
- Next Choice One Dose
- Nor-qd
- Nora-be
- norelgestrom-ethinyl estradiol
- noreth-ethinyl estradiol-iron
- norethin-e.estradiol triphasic
- norethin-eth estrad biphasic
- norethindrone (contraceptive)
- norethindrone ac-eth estradiol
- norethindrone-e.estradiol-iron
- norethindrone-ethin estradiol
- norethindrone-mestranol
- norgestimate-ethinyl estradiol
- norgestrel-ethinyl estradiol
- Norinyl 1+35 (28)
- Norinyl 1+50 (28)
- Nortrel 0.5/35 (28)
- Nortrel 1/35 (21)
- Nortrel 1/35 (28)
- Nortrel 7/7/7 (28)
- Nuvaring
- Ocella
- Ogestrel (28)
- Orsythia
- Ortho Evra
- Ortho Micronor
- Ortho Tri-cyclen (28)
- Ortho Tri-cyclen Lo (28)
- Ortho-cept (28)
- Ortho-cyclen (28)
- Ortho-novum 1/35 (28)
- Ortho-novum 7/7/7 (28)
- Ovcon-35 (28)
- Philith
- Pimtrea (28)
- Pirmella
- Plan B One-step
- Portia
- Previfem
- Quartette
- Quasense
- Reclipsen (28)
- Safyral
- Seasonique
- Simbrinza
- Skyla
- Sprintec (28)
- Sronyx
- Syeda
- Tilia Fe
- Tri-estarylla
- Tri-legest Fe
- Tri-linyah
- Tri-norinyl (28)
- Tri-previfem (28)
- Tri-sprintec (28)
- Trinessa (28)
- Trivora (28)
- Trusopt
- Velivet Triphasic Regimen (28)
- Vestura (28)
- Viorele (28)
- Vyfemla (28)
- Wera (28)
- Wymzya Fe
- Yasmin (28)
- Yaz 28
- Zarah
- Zenchent (28)
- Zenchent Fe
- Zeosa
- Zovia 1/35E (28)
- Zovia 1/50E (28)
Severe
Moderate
- Depacon
- Depakene
- Depakote
- Depakote Er
- Depakote Sprinkles
- divalproex
- Stavzor
- valproate sodium
- valproic acid
- valproic acid (as sodium salt)
- Secondary angle-closure glaucoma
Contraindicated
- Acute confusion
- Chronic kidney disease stage 3A (moderate) GFR 45-59
- Chronic kidney disease stage 3B (moderate) GFR 30-44
- Chronic kidney disease stage 4 (severe) GFR 15-29 ml/min
- Chronic kidney disease stage 5 (failure) GFr<15 ml/min
- Concentration difficulty
- Depression
- Fever
- Kidney disease with likely reduction in GFR
- Memory impairment
- Metabolic acidosis
- Ocular hypertension
- Pregnancy
- Reduced visual acuity
- Suicidal ideation
Severe
Moderate
- Arginase deficiency
- Arginosuccinate lyase deficiency
- Carbamoyl phosphate synthetase deficiency
- Citrullinemia
- Diarrhea
- Disease of liver
- Hyperammonemia in n-acetylglutamate synthase deficiency
- Kidney stone
- Ornithine carbamoyltransferase deficiency
- Paresthesia
TOPIRAMATE (TOPIRAMATE)
- Complex-partial epilepsy
- Migraine prevention
- Simple-partial epilepsy
- Lennox-gastaut epilepsy
- Tonic-clonic epilepsy
- None
- Acute abdominal pain
- Acute confusion
- Anorexia
- Behavioral disorders
- Bradykinesia
- Concentration difficulty
- Diplopia
- Dizziness
- Drowsy
- Dysarthria
- Dysmenorrhea
- Fatigue
- Fever
- Flushing
- General weakness
- Hypesthesia
- Insomnia
- Irregular menstrual periods
- Mastalgia
- Memory impairment
- Nausea
- Nervousness
- Nystagmus
- Paresthesia
- Weight loss
More Frequent
Severe
Less Severe
- Infection
- Kidney stone
- Leukopenia
- Aggressive behavior
- Agitation
- Alopecia
- Altered mental status
- Arthralgias
- Ataxia
- Back pain
- Bronchitis
- Chest pain
- Constipation
- Cough
- Depression
- Diarrhea
- Dysgeusia
- Dyspepsia
- Ecchymosis
- Edema
- Epistaxis
- Gastroenteritis
- Gingivitis
- Hemorrhage
- Hypertonia
- Involuntary muscle movement
- Libido changes
- Limb pain
- Mood changes
- Pharyngitis
- Premature ejaculation
- Purpura
- Rhinitis
- Sinusitis
- Symptoms of anxiety
- Tinnitus
- Tremor
- Upper respiratory infection
- Urinary tract infection
- Viral infection
- Vomiting
- Xerostomia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anemia
- Asthma
- Bullous dermatitis
- Decreased sweating
- Drug-induced psychosis
- Encephalopathy
- Eosinophilia
- Erythema multiforme
- Hallucinations
- Hepatic failure
- Hepatitis
- Hyperammonemia
- Hypotension
- Hypothermia
- Kidney disease with reduction in GFR
- Maculopathy
- Metabolic acidosis
- Myopia
- Nephrocalcinosis
- Ocular hypertension
- Pancreatitis
- Pemphigus
- Pneumonia
- Scotomata
- Secondary angle-closure glaucoma
- Stevens-johnson syndrome
- Suicidal
- Suicidal ideation
- Toxic epidermal necrolysis
Less Severe
- Abnormal vaginal bleeding
- Acne vulgaris
- Chills
- Conjunctivitis
- Dyspnea
- Dysuria
- Erectile dysfunction
- Flu-like symptoms
- Gastroesophageal reflux disease
- Gingival bleeding
- Headache disorder
- Hematuria
- Hyperhidrosis
- Increased urinary frequency
- Myalgias
- Ocular pain
- Ocular redness
- Orthostatic hypotension
- Polydipsia
- Pruritus of skin
- Skin rash
- Syncope
- Urinary incontinence
- Vertigo
- Visual changes
- Visual field defect
- Vulvovaginal candidiasis
Contraindicated
None
Severe Precaution
Topiramate (immed release)
Potential risk of metabolic acidosis, slowed growth, infection, hyperthermia, oligohidrosis, increased creatinine, hyperammonemia, secondary angle closure glaucoma. Efficacy not demonstrated age <2 years.
- 1 Day – 2 Years
- Potential risk of metabolic acidosis, slowed growth, infection, hyperthermia, oligohidrosis, increased creatinine, hyperammonemia, secondary angle closure glaucoma. Efficacy not demonstrated age <2 years.
Management or Monitoring Precaution
Topiramate (immed release)
Risk of acidosis, hyperammonemia, oligohidrosis and rarely angle closure glaucoma. Monitor serum bicarbonate, signs of encephalopathy (ammonia level), changes in behavior and vision, and check growth rate.
- 2 Years – 18 Years
- Risk of acidosis, hyperammonemia, oligohidrosis and rarely angle closure glaucoma. Monitor serum bicarbonate, signs of encephalopathy (ammonia level), changes in behavior and vision, and check growth rate.
Topiramate
- Severity Level:
D
- Additional Notes: Data from pregnancy registry show increased risk of orofacial cleft
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Topiramate
Monitor for signs of toxicity; may cause sedation,irritability,feeding problm
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Monitor for signs of toxicity; may cause sedation,irritability,feeding problm |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Topiramate
Renal-Decrease dose for CrCl < 70 mL/min. to minimize CNS toxicities. Neuro/Psych-Can cause cognitive impairment, ataxia, impaired psychomotor function, syncope, and increase risk for additional falls in those predisposed. Vision-Visual field defects have been reported in patients receiving topiramate independent of elevated intraocular pressure. In clinical trials, most of these events were reversible after topiramate discontinuation.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | N | N | Y | N | N |
BEERS: Y HEDIS: Y STOPP: Y
No Known Risk
None
- None
| Complex-partial epilepsy | |
| G40.0 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset |
| G40.00 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable |
| G40.009 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus |
| G40.01 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable |
| G40.019 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus |
| G40.2 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures |
| G40.20 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable |
| G40.209 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus |
| G40.21 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable |
| G40.219 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus |
| Lennox-gastaut epilepsy | |
| G40.81 | Lennox-gastaut syndrome |
| G40.812 | Lennox-gastaut syndrome, not intractable, without status epilepticus |
| G40.814 | Lennox-gastaut syndrome, intractable, without status epilepticus |
| Migraine prevention | |
| G43 | Migraine |
| G43.0 | Migraine without aura |
| G43.00 | Migraine without aura, not intractable |
| G43.009 | Migraine without aura, not intractable, without status migrainosus |
| G43.01 | Migraine without aura, intractable |
| G43.019 | Migraine without aura, intractable, without status migrainosus |
| G43.1 | Migraine with aura |
| G43.10 | Migraine with aura, not intractable |
| G43.109 | Migraine with aura, not intractable, without status migrainosus |
| G43.11 | Migraine with aura, intractable |
| G43.119 | Migraine with aura, intractable, without status migrainosus |
| G43.4 | Hemiplegic migraine |
| G43.40 | Hemiplegic migraine, not intractable |
| G43.409 | Hemiplegic migraine, not intractable, without status migrainosus |
| G43.41 | Hemiplegic migraine, intractable |
| G43.419 | Hemiplegic migraine, intractable, without status migrainosus |
| G43.5 | Persistent migraine aura without cerebral infarction |
| G43.50 | Persistent migraine aura without cerebral infarction, not intractable |
| G43.509 | Persistent migraine aura without cerebral infarction, not intractable, without status migrainosus |
| G43.51 | Persistent migraine aura without cerebral infarction, intractable |
| G43.519 | Persistent migraine aura without cerebral infarction, intractable, without status migrainosus |
| G43.6 | Persistent migraine aura with cerebral infarction |
| G43.60 | Persistent migraine aura with cerebral infarction, not intractable |
| G43.609 | Persistent migraine aura with cerebral infarction, not intractable, without status migrainosus |
| G43.61 | Persistent migraine aura with cerebral infarction, intractable |
| G43.619 | Persistent migraine aura with cerebral infarction, intractable, without status migrainosus |
| G43.7 | Chronic migraine without aura |
| G43.70 | Chronic migraine without aura, not intractable |
| G43.709 | Chronic migraine without aura, not intractable, without status migrainosus |
| G43.71 | Chronic migraine without aura, intractable |
| G43.719 | Chronic migraine without aura, intractable, without status migrainosus |
| G43.8 | Other migraine |
| G43.80 | Other migraine, not intractable |
| G43.809 | Other migraine, not intractable, without status migrainosus |
| G43.81 | Other migraine, intractable |
| G43.819 | Other migraine, intractable, without status migrainosus |
| G43.82 | Menstrual migraine, not intractable |
| G43.829 | Menstrual migraine, not intractable, without status migrainosus |
| G43.83 | Menstrual migraine, intractable |
| G43.839 | Menstrual migraine, intractable, without status migrainosus |
| G43.9 | Migraine, unspecified |
| G43.90 | Migraine, unspecified, not intractable |
| G43.909 | Migraine, unspecified, not intractable, without status migrainosus |
| G43.91 | Migraine, unspecified, intractable |
| G43.919 | Migraine, unspecified, intractable, without status migrainosus |
| G43.B | Ophthalmoplegic migraine |
| G43.B0 | Ophthalmoplegic migraine, not intractable |
| G43.B1 | Ophthalmoplegic migraine, intractable |
| G43.C | Periodic headache syndromes in child or adult |
| G43.C0 | Periodic headache syndromes in child or adult, not intractable |
| G43.C1 | Periodic headache syndromes in child or adult, intractable |
| G43.D | Abdominal migraine |
| G43.D0 | Abdominal migraine, not intractable |
| G43.D1 | Abdominal migraine, intractable |
| Simple-partial epilepsy | |
| G40.0 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset |
| G40.00 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable |
| G40.009 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus |
| G40.01 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable |
| G40.019 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus |
| G40.1 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures |
| G40.10 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable |
| G40.109 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus |
| G40.11 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable |
| G40.119 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, without status epilepticus |
| Tonic-clonic epilepsy | |
| G40.3 | Generalized idiopathic epilepsy and epileptic syndromes |
| G40.30 | Generalized idiopathic epilepsy and epileptic syndromes, not intractable |
| G40.309 | Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus |
| G40.31 | Generalized idiopathic epilepsy and epileptic syndromes, intractable |
| G40.319 | Generalized idiopathic epilepsy and epileptic syndromes, intractable, without status epilepticus |
| G40.4 | Other generalized epilepsy and epileptic syndromes |
| G40.40 | Other generalized epilepsy and epileptic syndromes, not intractable |
| G40.409 | Other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus |
| G40.41 | Other generalized epilepsy and epileptic syndromes, intractable |
| G40.419 | Other generalized epilepsy and epileptic syndromes, intractable, without status epilepticus |
| 0-9 | A-Z |
|---|---|
| G40.0 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset |
| G40.0 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset |
| G40.00 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable |
| G40.00 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable |
| G40.009 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus |
| G40.009 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus |
| G40.01 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable |
| G40.01 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable |
| G40.019 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus |
| G40.019 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus |
| G40.1 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures |
| G40.10 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable |
| G40.109 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus |
| G40.11 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable |
| G40.119 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, without status epilepticus |
| G40.2 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures |
| G40.20 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable |
| G40.209 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus |
| G40.21 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable |
| G40.219 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus |
| G40.3 | Generalized idiopathic epilepsy and epileptic syndromes |
| G40.30 | Generalized idiopathic epilepsy and epileptic syndromes, not intractable |
| G40.309 | Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus |
| G40.31 | Generalized idiopathic epilepsy and epileptic syndromes, intractable |
| G40.319 | Generalized idiopathic epilepsy and epileptic syndromes, intractable, without status epilepticus |
| G40.4 | Other generalized epilepsy and epileptic syndromes |
| G40.40 | Other generalized epilepsy and epileptic syndromes, not intractable |
| G40.409 | Other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus |
| G40.41 | Other generalized epilepsy and epileptic syndromes, intractable |
| G40.419 | Other generalized epilepsy and epileptic syndromes, intractable, without status epilepticus |
| G40.81 | Lennox-gastaut syndrome |
| G40.812 | Lennox-gastaut syndrome, not intractable, without status epilepticus |
| G40.814 | Lennox-gastaut syndrome, intractable, without status epilepticus |
| G43 | Migraine |
| G43.0 | Migraine without aura |
| G43.00 | Migraine without aura, not intractable |
| G43.009 | Migraine without aura, not intractable, without status migrainosus |
| G43.01 | Migraine without aura, intractable |
| G43.019 | Migraine without aura, intractable, without status migrainosus |
| G43.1 | Migraine with aura |
| G43.10 | Migraine with aura, not intractable |
| G43.109 | Migraine with aura, not intractable, without status migrainosus |
| G43.11 | Migraine with aura, intractable |
| G43.119 | Migraine with aura, intractable, without status migrainosus |
| G43.4 | Hemiplegic migraine |
| G43.40 | Hemiplegic migraine, not intractable |
| G43.409 | Hemiplegic migraine, not intractable, without status migrainosus |
| G43.41 | Hemiplegic migraine, intractable |
| G43.419 | Hemiplegic migraine, intractable, without status migrainosus |
| G43.5 | Persistent migraine aura without cerebral infarction |
| G43.50 | Persistent migraine aura without cerebral infarction, not intractable |
| G43.509 | Persistent migraine aura without cerebral infarction, not intractable, without status migrainosus |
| G43.51 | Persistent migraine aura without cerebral infarction, intractable |
| G43.519 | Persistent migraine aura without cerebral infarction, intractable, without status migrainosus |
| G43.6 | Persistent migraine aura with cerebral infarction |
| G43.60 | Persistent migraine aura with cerebral infarction, not intractable |
| G43.609 | Persistent migraine aura with cerebral infarction, not intractable, without status migrainosus |
| G43.61 | Persistent migraine aura with cerebral infarction, intractable |
| G43.619 | Persistent migraine aura with cerebral infarction, intractable, without status migrainosus |
| G43.7 | Chronic migraine without aura |
| G43.70 | Chronic migraine without aura, not intractable |
| G43.709 | Chronic migraine without aura, not intractable, without status migrainosus |
| G43.71 | Chronic migraine without aura, intractable |
| G43.719 | Chronic migraine without aura, intractable, without status migrainosus |
| G43.8 | Other migraine |
| G43.80 | Other migraine, not intractable |
| G43.809 | Other migraine, not intractable, without status migrainosus |
| G43.81 | Other migraine, intractable |
| G43.819 | Other migraine, intractable, without status migrainosus |
| G43.82 | Menstrual migraine, not intractable |
| G43.829 | Menstrual migraine, not intractable, without status migrainosus |
| G43.83 | Menstrual migraine, intractable |
| G43.839 | Menstrual migraine, intractable, without status migrainosus |
| G43.9 | Migraine, unspecified |
| G43.90 | Migraine, unspecified, not intractable |
| G43.909 | Migraine, unspecified, not intractable, without status migrainosus |
| G43.91 | Migraine, unspecified, intractable |
| G43.919 | Migraine, unspecified, intractable, without status migrainosus |
| G43.B | Ophthalmoplegic migraine |
| G43.B0 | Ophthalmoplegic migraine, not intractable |
| G43.B1 | Ophthalmoplegic migraine, intractable |
| G43.C | Periodic headache syndromes in child or adult |
| G43.C0 | Periodic headache syndromes in child or adult, not intractable |
| G43.C1 | Periodic headache syndromes in child or adult, intractable |
| G43.D | Abdominal migraine |
| G43.D0 | Abdominal migraine, not intractable |
| G43.D1 | Abdominal migraine, intractable |
Formulary Reference Tool